TY - JOUR
T1 - Information-guided surgical management of gliomas using low-field-strength intraoperative MRI.
AU - Muragaki, Yoshihiro
AU - Iseki, Hiroshi
AU - Maruyama, Takashi
AU - Tanaka, Masahiko
AU - Shinohara, Chie
AU - Suzuki, Takashi
AU - Yoshimitsu, Kitaro
AU - Ikuta, Soko
AU - Hayashi, Motohiro
AU - Chernov, Mikhail
AU - Hori, Tomokatsu
AU - Okada, Yoshikazu
AU - Takakura, Kintomo
N1 - Funding Information:
The authors are thankful to Drs. Osami Kubo, Ken’ichi Hirasawa, Takemasa Kawamoto, Kosaku Amano, Yuichi Kubota, Tatsuya Ishikawa, Atsushi Watanabe, and Ayako Horiba (Department of Neurosurgery, Tokyo Women’s Medical University) for their help with the present study. This work was supported by the Industrial Technology Research Grant Program in 2000–2005 (A45003a) from the New Energy and Industrial Technology Development Organization of Japan (to Y. Muragaki). The research activities of Drs. H. Iseki, M. Chernov, and K. Takakura are supported by the Program for Promoting the Establishment of Strategic Research Centers, Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science and Technology (Japan).
PY - 2011
Y1 - 2011
N2 - Contemporary technological developments revolutionized management of brain tumors. The experience with information-guided surgery of gliomas, based on the integration of the various intraoperative anatomical, functional, and histological data, is reported. From 2000 to 2009, 574 surgeries for intracranial gliomas were performed in our clinic with the use of intraoperative MRI (ioMRI) with magnetic field strength of 0.3T, updated neuronavigation, neurochemical navigation with 5-aminolevulinic acid, serial intraoperative histopathological investigations of the resected tissue, and comprehensive neurophysiological monitoring. Nearly half of patients (263 cases; 45.8%) were followed more than 2 years after surgery. Maximal possible tumor resection, defined as radiologically complete tumor removal or subtotal removal leaving the residual neoplasm within the vital functionally-important brain areas, was attained in 569 cases (99.1%). The median resection rate constituted 95%, 95%, and 98%, for WHO grade II, III, and IV gliomas, respectively. Actuarial 5-year survival was significantly worse in WHO grade IV gliomas (19%), but did not differ significantly between WHO grade III and II tumors (69% vs. 87%). Information-guided management of gliomas using low-field-strength ioMRI provides a good opportunity for maximal possible tumor resection, and may result in survival advantage, particularly in patients with WHO grade III neoplasms.
AB - Contemporary technological developments revolutionized management of brain tumors. The experience with information-guided surgery of gliomas, based on the integration of the various intraoperative anatomical, functional, and histological data, is reported. From 2000 to 2009, 574 surgeries for intracranial gliomas were performed in our clinic with the use of intraoperative MRI (ioMRI) with magnetic field strength of 0.3T, updated neuronavigation, neurochemical navigation with 5-aminolevulinic acid, serial intraoperative histopathological investigations of the resected tissue, and comprehensive neurophysiological monitoring. Nearly half of patients (263 cases; 45.8%) were followed more than 2 years after surgery. Maximal possible tumor resection, defined as radiologically complete tumor removal or subtotal removal leaving the residual neoplasm within the vital functionally-important brain areas, was attained in 569 cases (99.1%). The median resection rate constituted 95%, 95%, and 98%, for WHO grade II, III, and IV gliomas, respectively. Actuarial 5-year survival was significantly worse in WHO grade IV gliomas (19%), but did not differ significantly between WHO grade III and II tumors (69% vs. 87%). Information-guided management of gliomas using low-field-strength ioMRI provides a good opportunity for maximal possible tumor resection, and may result in survival advantage, particularly in patients with WHO grade III neoplasms.
UR - http://www.scopus.com/inward/record.url?scp=79952278616&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952278616&partnerID=8YFLogxK
U2 - 10.1007/978-3-211-99651-5_11
DO - 10.1007/978-3-211-99651-5_11
M3 - Article
C2 - 20960323
AN - SCOPUS:79952278616
SN - 0065-1419
VL - 109
SP - 67
EP - 72
JO - Acta neurochirurgica. Supplement
JF - Acta neurochirurgica. Supplement
ER -